14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 10, 2024 Buy 61 100 Campbell Shannon Stock Option (Right to Buy)
Apr 10, 2024 Buy 61 100 Raman Prakash Stock Option (Right to Buy)
Apr 10, 2024 Buy 0 Campbell Shannon
Apr 10, 2024 Buy 0 Raman Prakash
Mar 15, 2024 Buy 3 166 Behbahani Ali Common Stock
Mar 15, 2024 Buy 3 253 Dixon Wendy L Common Stock
Feb 14, 2024 Buy 200 000 Ni Fang Stock Option (Right to Buy)
Feb 14, 2024 Buy 200 000 Hatzis-schoch Brent Stock Option (Right to Buy)
Feb 14, 2024 Buy 225 000 Yurasov Sergey Stock Option (Right to Buy)
Feb 14, 2024 Buy 200 000 Buck Elizabeth Stock Option (Right to Buy)
Feb 14, 2024 Buy 537 000 Velleca Mark A. Stock Option (Right to Buy)
Feb 14, 2024 Buy 100 000 Jones Erika Stock Option (Right to Buy)
Dec 15, 2023 Buy 4 455 Behbahani Ali Common Stock
Dec 15, 2023 Buy 4 043 Dixon Wendy L Common Stock
Oct 17, 2023 Buy 400 000 Biotech Growth N V Common Stock
Sep 17, 2023 Buy 1 000 000 Velleca Mark A. Stock Option (Right to Buy)
Sep 15, 2023 Buy 3 299 Behbahani Ali Common Stock
Sep 15, 2023 Buy 5 208 Velleca Mark A. Common Stock
Sep 15, 2023 Buy 2 986 Dixon Wendy L Common Stock
Jul 05, 2023 Buy 935 850 Ra Capital Management, L.p. Common Stock
Jul 05, 2023 Buy 1 000 000 Behbahani Ali Common Stock
Jun 30, 2023 Buy 1 000 000 Biotech Growth N V Common Stock
Jun 27, 2023 Buy 1 740 000 Biotech Growth N V Common Stock
Jun 27, 2023 Sell 25 000 Epstein David M. Common Stock
Jun 16, 2023 Buy 5 655 Behbahani Ali Common Stock
Jun 16, 2023 Buy 5 119 Dixon Wendy L Common Stock
Jun 16, 2023 Buy 8 929 Velleca Mark A. Common Stock
May 16, 2023 Buy 16 500 Behbahani Ali Stock Option (right to buy)
May 16, 2023 Buy 16 500 Mayweg Alexander Stock Option (Right to Buy)
May 16, 2023 Buy 16 500 Shah Rajeev M. Stock Option (Right to Buy)
May 16, 2023 Buy 16 500 Velleca Mark A. Stock Option (Right to Buy)
May 16, 2023 Buy 16 500 Menzel Garry E Stock Option (Right to Buy)
May 16, 2023 Buy 16 500 Kulkarni Samarth Stock Option (Right to Buy)
May 16, 2023 Buy 16 500 Dixon Wendy L Stock Option (Right to Buy)
May 16, 2023 Buy 16 500 Dhingra Kapil Stock Option (Right to Buy)
Mar 16, 2023 Buy 7 111 Behbahani Ali Common Stock
Mar 16, 2023 Buy 6 437 Dixon Wendy L Common Stock
Mar 16, 2023 Buy 11 228 Velleca Mark A. Common Stock
Feb 13, 2023 Buy 250 000 Yurasov Sergey Stock Option (Right to Buy)
Feb 13, 2023 Buy 400 000 Ni Fang Stock Option (Right to Buy)
Feb 13, 2023 Buy 60 000 Jones Erika Stock Option (Right to Buy)
Feb 13, 2023 Buy 5 075 Jones Erika Common Stock
Feb 13, 2023 Buy 420 000 Epstein David M. Stock Option (Right to Buy)
Feb 13, 2023 Buy 200 000 Buck Elizabeth Stock Option (Right to Buy)
Feb 13, 2023 Buy 200 000 Hatzis-schoch Brent Stock Option (Right to Buy)
Dec 22, 2022 Buy 36 363 Ni Fang Common Stock
Dec 21, 2022 Buy 20 000 Ni Fang Common Stock
Dec 16, 2022 Buy 7 917 Behbahani Ali Common Stock
Dec 16, 2022 Buy 8 424 Velleca Mark A. Common Stock
Dec 16, 2022 Buy 7 167 Dixon Wendy L Common Stock
Dec 16, 2022 Buy 9 375 Ingram Robert Alexander Common Stock
Oct 31, 2022 Buy 99 801 Biotech Growth N V Common Stock
Oct 28, 2022 Buy 172 974 Biotech Growth N V Common Stock
Oct 27, 2022 Buy 191 678 Biotech Growth N V Common Stock
Oct 21, 2022 Buy 87 850 Biotech Growth N V Common Stock
Oct 20, 2022 Buy 53 734 Biotech Growth N V Common Stock
Oct 19, 2022 Buy 77 689 Biotech Growth N V Common Stock
Sep 16, 2022 Buy 4 532 Behbahani Ali Common Stock
Sep 16, 2022 Buy 4 103 Dixon Wendy L Common Stock
Sep 16, 2022 Buy 4 294 Velleca Mark A. Common Stock
Sep 16, 2022 Buy 6 584 Ingram Robert Alexander Common Stock
Jun 29, 2022 Buy 25 000 Ni Fang Common Stock
Jun 17, 2022 Buy 4 946 Dixon Wendy L Common Stock
Jun 17, 2022 Buy 5 850 Behbahani Ali Common Stock
Jun 17, 2022 Buy 5 542 Velleca Mark A. Common Stock
Jun 17, 2022 Buy 4 060 Dixon Wendy L Common Stock
Jun 17, 2022 Buy 8 498 Ingram Robert Alexander Common Stock
Jun 10, 2022 Buy 250 000 Yurasov Sergey Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Mayweg Alexander Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Behbahani Ali Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Behbahani Ali Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Velleca Mark A. Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Velleca Mark A. Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Shah Rajeev M. Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Ingram Robert Alexander Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Ingram Robert Alexander Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Dhingra Kapil Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Dhingra Kapil Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Menzel Garry E Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Menzel Garry E Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Kulkarni Samarth Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Kulkarni Samarth Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Dixon Wendy L Stock Option (Right to Buy)
Jun 10, 2022 Buy 15 000 Dixon Wendy L Stock Option (Right to Buy)
Apr 28, 2022 Buy 255 711 Biotech Growth N V Common Stock
Apr 27, 2022 Buy 150 000 Bb Biotech Ag Common Stock
Apr 27, 2022 Buy 150 000 Biotech Growth N V Common Stock
Apr 19, 2022 Buy 150 000 Biotech Growth N V Common Stock
Apr 18, 2022 Buy 150 000 Biotech Growth N V Common Stock
Apr 18, 2022 Buy 150 000 Bb Biotech Ag Common Stock
Apr 13, 2022 Buy 102 556 Biotech Growth N V Common Stock
Apr 12, 2022 Buy 150 000 Biotech Growth N V Common Stock
Apr 12, 2022 Buy 150 000 Bb Biotech Ag Common Stock
Apr 11, 2022 Buy 0 Biotech Growth N V Common Stock
Apr 06, 2022 Buy 30 000 Dixon Wendy L Stock Option (Right to Buy)
Apr 06, 2022 Buy 30 000 Dixon Wendy L Stock Option (Right to Buy)
Apr 06, 2022 Buy 0 Dixon Wendy L
Mar 18, 2022 Buy 4 346 Behbahani Ali Common Stock
Mar 18, 2022 Buy 5 795 Ingram Robert Alexander Common Stock
Mar 18, 2022 Buy 2 897 Velleca Mark A. Common Stock
INSIDER POWER
95.820
Last 100 transactions
Buy: 12 215 700 | Sell: 25 000 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 95.820.

In total, the insiders bought 12 215 700 and sold 25 000 BDTX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Black Diamond Therapeutics Inc.

Black Diamond Therapeutics. Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penet... BDTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT